<DOC>
	<DOCNO>NCT00552409</DOCNO>
	<brief_summary>This study assess effect vitamin D3 supplementation ( cholecalciferol ; 2000 IU daily ) serum calcium level , circulate vitamin D level , marker kidney disease cardiovascular risk among people diabetes mellitus early kidney disease . Eligibility criterion include type 2 diabetes stage 1-2 chronic kidney disease , define urine albumin-creatinine ratio 30-300 mg/g estimate glomerular filtration rate â‰¥ 60 mL/min . Participants randomly assign treatment vitamin D3 placebo , take mouth daily study duration one year . Study medication add standard treatment , include angiotensin convert enzyme inhibitor and/or angiotensin II receptor blocker . We hypothesize vitamin D3 , compare placebo : ( 1 ) well-tolerated safe among people diabetes kidney disease ; ( 2 ) result adequate attained circulate vitamin D level ; ( 3 ) positively affect marker kidney disease cardiovascular risk .</brief_summary>
	<brief_title>Randomized Controlled Trial Vitamin D3 Diabetic Kidney Disease</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Diabetic Nephropathies</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Clinical diagnosis type 2 diabetes mellitus Urine albumincreatinine ratio 301000 mg/g Estimated glomerular filtration rate great equal 60 mL/min Treatment angiotensin convert enzyme inhibitor and/or angiotensin II receptor blocker great equal 6 month , stable dose great equal 3 month Blood pressure le 140/90 ( assess take medication ) Hemoglobin A1c le 9 % ( assessed take medication ) 25hydroxyvitamin D less 30 ng/mL Prior dialysis kidney transplantation Known cause albuminuria diabetes Planning leave area within 12 month Life expectancy le 12 month Participation another clinical trial within 6 month Osteoporosis establish indication vitamin D therapy Vitamin D3 supplement intake great 400 IU/day screen visit History nephrolithiasis Serum calcium great 10.2 mg/dL Dementia , fluent English , unable provide inform consent without proxy respondent Incontinent urine Failure take great equal 80 % placebo pill study runin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Diabetes mellitus</keyword>
	<keyword>Type 2 diabetes</keyword>
	<keyword>Chronic kidney disease</keyword>
	<keyword>Diabetic kidney disease</keyword>
	<keyword>Microalbuminuria</keyword>
	<keyword>Albuminuria</keyword>
	<keyword>Vitamin D</keyword>
	<keyword>Cholecalciferol</keyword>
	<keyword>Kidney</keyword>
	<keyword>Renal</keyword>
	<keyword>Cardiovascular</keyword>
	<keyword>Clinical trial</keyword>
	<keyword>Placebo</keyword>
</DOC>